Kotra Industries Bhd wins two awards in the healthcare sector at The Edge Malaysia Centurion Club Corporate Awards 2025. The company ends a four-year streak of taking all three awards in its category. This recognition highlights Kotra’s continued leadership in Malaysia’s pharmaceutical industry.
Kotra Industries Bhd reports a **4.5% decline in 4Q net profit to RM12.49 million**, down from RM13.09 million in the same period last year. The drop stems from increased tax expenses, as stated in its financial report for the quarter ending **June 30, 2024**. The company operates in the pharmaceutical sector and trades on the Kuala Lumpur Stock Exchange.
Kotra Industries reports a **61% decline in net profit to RM6.83 million** in 3QFY2024, down from RM17.5 million the prior year. The health products manufacturer attributes the drop to **lower sales and a less favorable product mix**. Higher tax expenses further impacted financial performance.
Kotra Industries reports a **29.22% drop in net profit** to **RM11.62 million** in 2QFY2024, driven by lower sales and slightly elevated costs. The pharmaceutical and healthcare products manufacturer adjusts its dividend to **12.5 sen** amid declining revenue. The decline follows a year-ago profit of **RM16.41 million** for the same quarter.
Kotra Industries Bhd reports a **25% net profit decline** to **RM13.66 million** (9.21 sen per share) in **1QFY2024**, down from **RM18.24 million** (12.33 sen per share) in the same period last year. The company attributes the drop to **lower revenue and weaker demand**. Results cover the quarter ended **September 30, 2023**.
Kotra Industries Bhd wins the Centurion of The Year award at The Edge Malaysia Centurion Club Corporate Awards 2023. The Melaka-based pharmaceutical company is recognized as the top performer among Bursa Malaysia-listed firms with a market capitalization under RM1 billion. The accolade highlights its strong performance in the listed small-cap segment.